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Abstract
Background: Insertion of a Totally Implantable Access Port (TIAP) can be performed either via Central Vein
Puncture (CVP) or Brachiocephalic Vein Cut-down (venous section-VS). The primary success rate of TIAP
implantation using VS rarely ever achieves 100%. The objective of this study was to describe a modified VS
approach using a hydrophilic coated wire (TVS).
Methods: From 01.01.2015 to 31.12.2015, all patients receiving TIAP implantations were screened. During this time,
all patients in whom the primary VS procedure was found to be unsuccessful were analysed.
Results: In 2015, 1152 patients had TIAP implantations performed by 24 different surgeons. Of these, 277 patients
needed a second line rescue strategy either by CVP (n = 69) or TVS (n = 208). There were no statistically significant
differences regarding demographics or indication for TIAP implantation between CVP and TVS. The operation time and
the qualification of the operating surgeon between CVP and TVS did not differ significantly. After the introduction of
the guidewire with a hydrophilic coated wire, the need for CVP decreased significantly from 12.7% to 8.8% (p < 0.0001).
In patients receiving CVP as a second line rescue strategy, the incidence of pneumothorax (n = 3 patients (4.3%)) was
significantly higher compared to patients with TVS as a second line rescue strategy (n = 1 patient (0.48%), p = 0.02).
Conclusion: The use of a hydrophilic coated wire significantly decreased the number of CVP and the incidence of
pneumothorax. TVS is a safe and successful second-line rescue strategy.
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Background
Since the first insertion of a Totally Implantable Access
Port (TIAP) in 1982, the use of this central venous ac-
cess system has increased dramatically over the last
years [1]. As an example, the total amount of implanted
TIAPs in Germany was over 125,000 in 2014 [2, 3].
Nowadays, TIAPs are not only used for chemotherapy in
cases of malignant diseases, but also for blood and blood
products transfusion, as well as, for the administration
of parenteral nutrition [1–7].
There are two main approaches used to implant a TIAP.
Firstly, via the direct puncture of a central vein (CVP) and
secondly, through a classical cut-down of the brachioce-
phalic vein (CVS). In recent years, the CVS was adapted
by using a guide-wire in a modified Seldinger technique
(MVS) [8, 9]. Both main approaches, i.e. the CVP and
CVS or the MVS, can be performed with low morbidity
[10, 11]. However, the risk of pleural injury with
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consecutive development of a pneumothorax will al-
ways exist when CVP is utilised [7, 12]. On the other
hand, the success rate of TIAP implantation via CVS/
MVS will never reach 100% [10, 13–17], since there will
be patients in whom CVS/MVS cannot be performed
because of the absence of a brachiocephalic vein or the
presence of one that is inadequate sized. Another rea-
son for an unsuccessful TIAP implantation by CVS/
MVS is a steep junction of the brachiocephalic vein
into the central venous system) [18–21].
Although the use of a guide-wire as a means of dealing
with a situation in which the catheter cannot be inserted
into the cephalic vein is a basic part of the MVS [22],
there have not been any specifications regarding the kind
of guide-wire to be used. However, clinical data derived
mostly from interventional radiologist series suggest that
there are guide-wires available that are either particularly
suited for small vessels or able to pass through steep
junctions of blood vessels [23]; the widely used Terumo®
Radifocus Guidewire M Standard (Terumo® wire) type is
one of these [24]. The Terumo® wire is a guide-wire with
a hydrophilic polymer coating, thus allowing for low
friction manoeuvrability. The aim of this study was to
examine the impact of this guide-wire (TVS) as a second
line rescue strategy in patients with primary TIAP
implantations.
Methods
This retrospective study was approved by the local ethics
committee of the University of Heidelberg (S-584/2016).
The study was conducted at the outpatient clinic of the
General Surgery Department, University of Heidelberg.
Funding was not provided.
Participants
The criterion for this study was to focus on all elective
TIAP insertions for either benign or malignant diseases
that were performed under local anaesthesia throughout
2015. A Flowchart of this retrospective study is shown in
Fig. 1. Based on previously published data [19] a follow-
up period of 6 months was established as sufficient in
order to detect possible complications after TIAP
Fig. 1 Flowchart of this retrospective study
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implantation. Complications during the first 30 days
after TIAP insertion were classified as early, while com-
plications presenting after that time were classified as
late complications.
Interventions
The principal techniques for CVP, CVS, and MVS, re-
spectively, have been described in detail in previous pub-
lications [22, 25]. The choice of the implantation side
was predominantly left to the patients’ discretion. In
general, all patients were positioned on the operating
table in a five-degree, reverse Trendelenburg’s position.
The neck, chest, and shoulders of the patients were pre-
pared and draped in a sterile manner. Antibiotic prophy-
laxis was given in cases where patients were at risk for
endocarditis (in accordance with the local standards) or
only if a TIAP was to be used for chemotherapy within
three days after implantation. Local anaesthesia was ad-
ministered in the prospective operation area under ster-
ile conditions and a 2–3 cm long skin incision was done
2–3 cm inferior of the clavicular base above the deltoid-
pectoral region. After exhibition of the cephalic vein, the
CVS technique was evaluated.
Implantation of TIAP using guidewire with a hydrophilic
coating (TVS, Figs. 2a-d)
In cases where the cephalic vein was either non-existent
or too small for CVS or MVS (Fig. 2b), the guidewire
with a hydrophilic coating wire was used. The TVS
started with ligation of the respective vessel (typically a
small cephalic vein or Ramus pectoralis that merges into
the V. thoracoacromialis) distally and encircled cranially
with a 3–0 absorbable suture. With the use of magnifica-
tion glasses and microsurgical instruments, a vein cut-
down was performed (Fig. 2c) and the hydrophilic
coated wire was inserted (Fig. 2d). Finally, the guide-
wire was placed under fluoroscopy to the junction of the
superior Vena Cava and right atrium. After positioning,
either the TIAP catheter or a vein dilator and sheath
were passed over the guide-wire. In cases where the
latter was performed, the guide-wire and dilator were re-
moved and the catheter was introduced through the
peel-away sheath. After removal of the peel-away sheath,
correct positioning of the implant was once again
checked via fluoroscopy. Subsequently, the steps for port
chamber connection and port chamber placement were
done as per in-house standards (as described in previous
publications) [22]. After CVP a routine x-ray was per-
formed postoperatively to evaluate for pneumothorax.
Objectives and outcomes
The primary aim was to establish whether or not the use
of a guidewire with a hydrophilic coating reduced the
number of punctures needed without correspondingly
increasing complication rates. Also, the aim was to es-
tablish that neither the patients’ characteristics nor the
surgeons’ experience play any significant role in the suc-
cessful use of this guide-wire. Secondary aims of this
Fig. 2 a-d Incision for Totally Implantable Access Port (TIAP) implantation according to: anatomical landmarks (a), with intraoperative situs (b),
Vein cut-down/Venae Sectio using microsurgical instruments (c), and insertion of the guidewire with a hydrophilic coating (Terumo ® wire) (d).
# Ramus pectoralis merging into V. thoracoacromialis. * Ramus pectoralis of A. thoracoacromialis
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study were to establish the independence of the results
in cases where the operation was performed by an at-
tending or a resident physician.
Statistical analysis
The complication rates and the baseline characteristics
were analysed with respect to the technique which was ac-
tually applied in each case. The success rate in the various
treatment groups was determined and subsequently com-
pared using the Kruskal-Wallis Test for continuous vari-
ables (Standard Deviation is provided in Tables 1 and 2)
and Chi-square for dichotomous variables.
The rates of complications per year were calculated
using a two-tailed chi-squared test. All analyses were
performed using SPSS version 21.
Results
In 2015, 1152 patients underwent operations that were
classified as ‘Insertions of Intravenous Devices’. Overall,
TIAP implantations were performed by 24 different sur-
geons, 9 of whom were board certified (data not shown).
Out of the 1152 patients, 1099 patients actually received
TIAP implantations, of which, the TIAP implantations
were successfully performed via classical vein cut-down
(CVS) in 822 cases (74.8%). Some 277 patients needed a
second line rescue strategy, either via a primary Central
Vein Puncture (CVP) or a modified vein cut-down using
the hydrophilic coated guide-wire (TVS, Fig. 1 and
Table 1). There were no statistically significant differ-
ences regarding demographics or indication for TIAP
implantation (Table 1, p > 0.1, p - values not shown) be-
tween CVP and TVS.
The operation time and the qualification of the operat-
ing surgeon between CVP and TVS showed no significant
differences (Table 2). It was found that the use of the
hydrophilic coated guide-wire as a second line rescue
strategy reduced the need for CVP significantly from
12.7% to 8.8%(p < 0.0001, Fig. 3). Regarding early morbid-
ity the incidence of pneumothorax was significantly higher
in patients receiving CVP as a second line rescue strategy
when compared to patients with TVS as a second line res-
cue strategy (p = 0.02, Table 2). There were no differences
between CVP and TVS (Table 2) as it relates to late mor-
bidity after TIAP implantation; this includes infection,
non-function, and/or removal of TIAP.
Discussion
Safety of the TVS strategy
The data presented on the 277 patients who needed a
second line rescue therapy during TIAP implantation al-
lows the conclusion, that the use of the hydrophilic
coated guide-wire as a second line rescue strategy sig-
nificantly reduces not only the puncture rate during
TIAP implantation, but also the incidence of pneumo-
thorax. It is true that in experienced hands TIAP im-
plantations can be performed safely whether or not CVP
or CVS with its modifications are being used. Even
though CVP includes a risk, per se, of developing of a
pneumothorax, the published data reports this complica-
tion in about 1–3.2% of all cases [10, 26–28]. The reason
to use primarily CVS and its modifications at our
department is based on the fact that we generally per-
form more than 1000 TIAP implantations per year. For
example, this means that even with a low, 3% incidence
rate of pneumothorax after CVP, 30 of our patients would
experience such complications on average. Furthermore,
TIAP implantations are considered a reliable teaching
procedure and will mostly be performed by residents
during the early course of their training [27, 29].
As stated before, TIAP implantation using CVS (and
its modifications) is not successful in all patients. It has
been shown, under conditions of a randomized
Table 1 Baseline Characteristics of Analysed Patients
All Patients n (%) Central Vein Puncture as a
second line rescue strategy n (%)
Use of guidewire with a hydrophilic coating
as a second line rescue strategy n (%)
n 277 69 208
Mean Age 58.7 years (SD ±15.1) 58.6 years (SD ±16.4) 58.7 years (SD ±15.1)
Female Patients 149 (53.7%) 38 (55.1%) 111 (53.4%)
Indication for TIAP Implantation
Gastrointestinal Malignancy 84 (30.3%) 19 (27.5%) 65 (31.2%)
Gynecological Malignancy 74 (26.7%) 20 (29.0%) 54 (26.0%)
Hematological Malignancy 59 (21.3%) 15 (21.7%) 44 (21.2%)
Other Malignancies/Reasons 60 (21.7%) 15 (21.7%) 45 (21.6%)
Patients with first TIAP implantation 245 (88.4%) 58 (84.1%) 187 (89.9%)
TIAP implantation on the patients’ left side 220 (79.4%) 58 (84.1%) 163 (78.4%)
Central Vein Puncture 100 (36.1%) 69 (100%) 31 (14.9%)
Abbreviations: SD = standard deviation, TIAP = Totally Implantable Access Port
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Fig. 3 Number of Totally Implantable Access Port (TIAP) implantations (black boxes) and percentage of performed Central Vein Punctures (CVP) (grey
circles) performed between 2012 and 2015. * The two-tailed p value is less than 0.0001 (as seen in a comparison of 2015 with 2014). # Up to December
2013, modified vein cut-down was performed by using a MHMedical Tec GmbH® guide-wire. The Terumo® wire was used sporadically in individual
patients throughout 2014; however, it was introduced systematically in 2015
Table 2 Intra- and postoperative data of Totally Implantable Access Port (TIAP) implantation using either Central Vein Puncture
(CVP) or modified vein cut-down using hydrophilic coated guide-wire (TVS) as a second line rescue strategy
All Patients n (%) Central Vein Puncture as a
second line rescue strategy n (%)
Use of guidewire with a hydrophilic
coating as a second line strategy n (%)
p*
n 277 69 208
Mean operation time (SD) 37.7 min
(± 20.9 min)
35.6 min
(± 16.8 min)
38.4 min
(± 22.2 min)
0.347
Operation performed by Resident alone (n) 76 (27.5%) 16 (23.2%) 60 (28.8%) 0.351
Operation performed by Attending alone (n) 171 (61.7%) 45 (65.2%) 126 (60.6%) 0.568
Operation performed by Resident and
Attending
30 (10.8%) 8 (11.6%) 22 (10.6%) 0.814
Early Morbidity
Intraoperative bleeding 3 (1%) 0 (0%) 3 (1%) 0.316
Pneumothorax 4 (1.4%) 3 (4.3%) 1 (0.5%) 0.020
Need for thorax drainage 1 (0.4%) 1 (1.4%) 0 (0%) 0.082
Late Morbidity
Thrombosis 2 (0.7%) 0 (0%) 2 (0.9%) 0.414
TIAP Infection 17 (6.1%) 3 (1.4%) 14 (6.7%) 0.475
Sepsis due to TIAP Infection 14 (5%) 2 (2.9%) 12 (5.7%) 0.346
Non-Function due to dislocation 8 (2.9%) 2 (2.9%) 6 (2.9%) 0.995
Pinch-off syndrome 1 (0.4%) 0 (0%) 1 (0.5%) 0.564
Postoperative hematoma 2 (0.7%) 0 (0%) 2 (0.9%) 0.414
Removal of TIAP 26 (9.4%) 6 (8.7%) 20 (9.6%) 0.803
Abbreviations: SD = standard deviation, TIAP = Totally Implantable Access Port, CVP = Central Vein Puncture, TVS = vein cut down using a guidewire with a
hydrophilic coating; Terumo® Venae Sectio
*p value determined according to the Kruskal Wallis Test for continuous variables and Chi-squared Test for dichotomous variables
Polychronidis et al. BMC Surgery  (2017) 17:131 Page 5 of 7
controlled trial, that TIAP implantation can be per-
formed successfully in 92% of patients by using CVS
[22]. However, the circumstances for TIAP implantation
in our study could best be described as “daily routine”.
Overall the frequency of complications is comparable to
the existing literature and much lower in the case of
thrombosis, suboptimal positioning or frequency of re-
moval [29–32]. There has been a –not statistically sig-
nificant- increased rate of infections in the study group
which could not be due to the slightly increased oper-
ation time. According to an analysis conducted in our
centre [19] some other reasons can account for this:
ongoing chemotherapy, the female gender and breast
cancer were recognized as independent and significant
parameters. In the study group, there are more female
patients with gynaecological malignancies, which could
explain this finding.
Retrospectively seen, the need for CVP averaged about
12% throughout the years in our centre. This, together
with the fact that an increasing number of patients with
a need for recurrent TIAP implantation and patients
with inadequately sized or even non-existent brachioce-
phalic vein, increases the need for appropriate and
applicable modification techniques for CVS.
Reproducibility and learning curve of the TVS strategy
At first glance, the process of TIAP implantation using
TVS (as described in Fig. 1) seems technically demand-
ing. However, the presented data has shown that the
operation time for TIAP implantation between CVP and
TVS do not differ significantly. In addition, 28.8% of the
residents were able to apply this technique safely by
themselves, while only 10.6% of cases required the sup-
port of an attending physician. This makes our findings,
that TVS reduces significantly not only the puncture
rate but also the incidence of pneumothorax even more
clinically valuable. With this in mind, it would be inter-
esting to examine the success and complication rates
between CVP and SVS, for instance, in a multicentre
expert-based setting.
Conclusion
TIAP implantation using a guidewire with a hydrophilic
coating significantly reduces the need for central vein
puncture and the incidence of pneumothorax. TVS can
be safely applied by surgeons at any stage of their train-
ing. Subsequently, it may even be beneficial to consider
TVS as a first line technique for TIAP implantation.
Abbreviations
CVP: Direct puncture of a central vein; CVS: Cut-down of the brachiocephalic
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